StockData
TRXBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

TRex Bio, Inc.

$14.80+0.79 (+5.64%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

TRex Bio, Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

TRex Bio does not break out revenue by segment, region or product in the tagged data of its filings for this period type.